Dao Wen Wang

1996–2025 年に発表

252
論文数
25,300
被引用数
87
h 指数
241
i10 指数

被引用数

Dao Wen Wang の年別被引用数1982 年: 被引用 1 件1995 年: 被引用 3 件1996 年: 被引用 2 件1997 年: 被引用 7 件1998 年: 被引用 8 件1999 年: 被引用 41 件2000 年: 被引用 50 件2001 年: 被引用 67 件2002 年: 被引用 62 件2003 年: 被引用 58 件2004 年: 被引用 64 件2005 年: 被引用 76 件2006 年: 被引用 81 件2007 年: 被引用 88 件2008 年: 被引用 117 件2009 年: 被引用 109 件2010 年: 被引用 102 件2011 年: 被引用 92 件2012 年: 被引用 98 件2013 年: 被引用 111 件2014 年: 被引用 120 件2015 年: 被引用 132 件2016 年: 被引用 106 件2017 年: 被引用 126 件2018 年: 被引用 133 件2019 年: 被引用 469 件2020 年: 被引用 1,249 件2021 年: 被引用 1,451 件2022 年: 被引用 1,109 件2023 年: 被引用 780 件2024 年: 被引用 1,315 件2025 年: 被引用 721 件2026 年: 被引用 25 件1983〜1994 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図中国: 引用元論文 2,746 件、この内訳の 22%アメリカ合衆国: 引用元論文 2,387 件、この内訳の 19.1%イギリス: 引用元論文 646 件、この内訳の 5.2%イタリア: 引用元論文 634 件、この内訳の 5.1%ドイツ: 引用元論文 546 件、この内訳の 4.4%カナダ: 引用元論文 315 件、この内訳の 2.5%インド: 引用元論文 313 件、この内訳の 2.5%オーストラリア: 引用元論文 302 件、この内訳の 2.4%フランス: 引用元論文 296 件、この内訳の 2.4%オランダ: 引用元論文 262 件、この内訳の 2.1%スペイン: 引用元論文 257 件、この内訳の 2%日本: 引用元論文 239 件、この内訳の 1.9%
0%22%その他 28.4%

分野

  • Medicine53.5%
  • Biochemistry, Genetics and Molecular Biology33.1%
  • Neuroscience2.7%
  • Immunology and Microbiology2.6%
  • Agricultural and Biological Sciences2.2%
  • Computer Science1.6%
  • その他4.3%

トピック

  • COVID-19 Clinical Research Studies4.9%
  • Long-Term Effects of COVID-192.7%
  • MicroRNA in disease regulation2.6%
  • Ion channel regulation and function2.6%
  • Cardiac electrophysiology and arrhythmias2.5%
  • SARS-CoV-2 and COVID-19 Research2.2%
  • その他82.5%

共著者

全論文

検索で開く
  1. Metabolism pathways of arachidonic acids: mechanisms and potential therapeutic targets

    著者: , , , , , , , , - Signal Transduction and Targeted Therapy 2021 被引用: 1,376

  2. The role of CD36 in cardiovascular disease

    著者: , , , , , - Cardiovascular Research 2020 被引用: 265

  3. AMPKα2 Protects Against the Development of Heart Failure by Enhancing Mitophagy via PINK1 Phosphorylation

    著者: , , , , , , , , - Circulation Research 2017 被引用: 324

  4. COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives

    著者: , , , , - Nature Reviews Cardiology 2020 被引用: 1,469

  5. Effectiveness of a non-physician community health-care provider-led intensive blood pressure intervention versus usual care on cardiovascular disease (CRHCP): an open-label, blinded-endpoint, cluster-randomised trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Shu Zhang, Qiyu Li, Qiying Qin, Canru Liu, Xiaoyu Zheng, Tao Wang, Tao Wang, Boqiang Zhang, Qun Sun, Yu Yan, Yue‐Yuan Liao, Qiong Ma, Chao Chu, Yue Sun, Dan Wang, Ling Zhou, Heng Ye, Haoran Wei, Hao Liu, Zhaoqing Sun, Liqiang Zheng, Yanli Chen, Chang Ye, Mohan Jiang, Hongmei Yang, Shasha Yu, Wenna Li, Ning Wang, Chun-Wei Wu, Lufan Sun, Zhi Du, Yan Li, Nan Gao, Xinchi Liu, Ying Wang, Mingang Huang, Yufang Zhou, Lingrui Meng, Jiawen Zhang, Zhen Huang, Huihui Chen, Yuxian Huang, Lingmin Sun, Xin Zhong, Hanmin Wang, Xinyan Hou, Huan Han, Baohui Jin, Hua He, Baohui Jin, Hua He - The Lancet 2023 被引用: 139

  6. Anti-SARS-CoV-2 activities in vitro of Shuanghuanglian preparations and bioactive ingredients

    著者: , , , , , , , , , , , , , , , , , , , , , , , - Acta Pharmacologica Sinica 2020 被引用: 456

  7. A village doctor-led multifaceted intervention for blood pressure control in rural China: an open, cluster randomised trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Qiyu Li, Qiying Qin, Canru Liu, Xiaoyu Zheng, Tao Wang, Li Jing, Boqiang Zhang, Qun Sun, Yu Yan, Yueyuan Liao, Qiong Ma, Chao Chu, Yue Sun, Yue Sun, Dan Wang, Ling Zhou, Heng Ye, Haoran Wei, Hao Liu, Zhaoqing Sun, Liqiang Zheng, Yanli Chen, Ye Chang, Mohan Jiang, Hongmei Yang, Shasha Yu, Wenna Li, Ning Wang, Chunwei Wu, Lufan Sun, Zhi Du, Yan Li, Nan Gao, Xinchi Liu, Ying Wang, Mingang Huang, Yufang Zhou, Lingrui Meng, Jiawen Zhang, Zhen Huang, Huihui Chen, Yuxian Huang, Lingmin Sun, Xin Zhong, Hanmin Wang, Xinyan Hou, Huan Han, Baohui Jin, Hua He - The Lancet 2022 被引用: 156

  8. LARP7 Protects Against Heart Failure by Enhancing Mitochondrial Biogenesis

    著者: , , , , , , , , , , , , , , , , , , , , , , - Circulation 2021 被引用: 123

  9. Nuclear miR-320 Mediates Diabetes-Induced Cardiac Dysfunction by Activating Transcription of Fatty Acid Metabolic Genes to Cause Lipotoxicity in the Heart

    著者: , , , , , , , , , , - Circulation Research 2019 被引用: 224

  10. COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options

    著者: , , , , , , , , , , , , , , , , , , , , , , , - Cardiovascular Research 2020 被引用: 1,503

  11. Gut microbiota production of trimethyl-5-aminovaleric acid reduces fatty acid oxidation and accelerates cardiac hypertrophy

    著者: , , , , , , , , , , , , , , , , , , , , , - Nature Communications 2022 被引用: 102

  12. Obesity and atrial fibrillation: a narrative review from arrhythmogenic mechanisms to clinical significance

    著者: , , , , , , , , - Cardiovascular Diabetology 2023 被引用: 105

  13. Untargeted metabolomics identifies succinate as a biomarker and therapeutic target in aortic aneurysm and dissection

    著者: , , , , , , , , , , , , , , , , , , , , - European Heart Journal 2021 被引用: 160

  14. MiR-30c/PGC-1β protects against diabetic cardiomyopathy via PPARα

    著者: , , , , , , , , - Cardiovascular Diabetology 2019 被引用: 114

  15. Acyl-CoA thioesterase 1 prevents cardiomyocytes from Doxorubicin-induced ferroptosis via shaping the lipid composition

    著者: , , , , , - Cell Death and Disease 2020 被引用: 110

  16. Elevated serum levels of S100A8/A9 and HMGB1 at hospital admission are correlated with inferior clinical outcomes in COVID-19 patients

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - Cellular and Molecular Immunology 2020 被引用: 275

  17. Cystathionine γ Lyase Sulfhydrates the RNA Binding Protein Human Antigen R to Preserve Endothelial Cell Function and Delay Atherogenesis

    著者: , , , , , , , , , , , , , , , , , , , , , , , - Circulation 2018 被引用: 147

  18. Glucagon‐like peptide‐1 ameliorates cardiac lipotoxicity in diabetic cardiomyopathy via the PPARα pathway

    著者: , , , , , , - Aging Cell 2018 被引用: 91

  19. Ganglioside GM3 Protects Against Abdominal Aortic Aneurysm by Suppressing Ferroptosis

    著者: , , , , , , , , , , , , , , , , - Circulation 2023 被引用: 75

  20. MicroRNA-21 Lowers Blood Pressure in Spontaneous Hypertensive Rats by Upregulating Mitochondrial Translation

    著者: , , , , , , , , , , - Circulation 2016 被引用: 176

  21. Genetic insights into therapeutic targets for aortic aneurysms: A Mendelian randomization study

    著者: , , , , , , , , , - EBioMedicine 2022 被引用: 81

  22. Atezolizumab, vemurafenib, and cobimetinib in patients with melanoma with CNS metastases (TRICOTEL): a multicentre, open-label, single-arm, phase 2 study

    著者: , , , , , , , , , , , , , , - The Lancet Oncology 2023 被引用: 57

  23. The Cell Type–Specific Functions of miR-21 in Cardiovascular Diseases

    著者: , , , , , , , , , , - Frontiers in Genetics 2020 被引用: 74

  24. Update on acute myocarditis

    著者: , , , , , , , , - Trends in Cardiovascular Medicine 2020 被引用: 145